In vitro activity of ceftaroline against community-associated methicillin-resistant, vancomycin-intermediate,

Louis Saravolatz1, Joan Pawlak, Leonard Johnson

  • 1St. John Hospital and Medical Center, 19251 Mack Ave., Suite 333, Detroit, MI 48236, USA. louis.saravolatz@stjohn.org

Insights

Ceftaroline shows strong in vitro activity against various resistant Staphylococcus aureus strains, including community-associated methicillin-resistant S. aureus (CA-MRSA). It also demonstrated bactericidal effects against difficult-to-treat isolates, offering a potential new treatment option.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Staphylococcus aureus is a significant human pathogen.
  • Increasing antimicrobial resistance in S. aureus poses a therapeutic challenge.
  • Novel antibiotics are needed to combat resistant strains.

Purpose of the Study:

  • To evaluate the in vitro antimicrobial activity of ceftaroline.
  • To compare ceftaroline's efficacy against various resistant Staphylococcus aureus phenotypes.
  • To assess ceftaroline's bactericidal potential against challenging S. aureus isolates.

Main Methods:

  • In vitro susceptibility testing of ceftaroline and comparator agents.
  • Testing against a diverse collection of Staphylococcus aureus isolates.
  • Characterization of isolates including CA-MRSA, VISA, VRSA, hVISA, and DNSSA.

Main Results:

  • Ceftaroline exhibited potent activity against community-associated methicillin-resistant S. aureus (CA-MRSA).
  • Ceftaroline demonstrated bactericidal activity against vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA), heteroresistant VISA (hVISA), and daptomycin-nonsusceptible S. aureus (DNSSA).

Conclusions:

  • Ceftaroline possesses significant in vitro activity against a range of resistant S. aureus.
  • The drug shows promise as a bactericidal agent for infections caused by these difficult-to-treat pathogens.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...